Navigation Links
Urocidin™ Phase III Clinical Trial Results to be Presented at EAU and AUA Conferences
Date:2/17/2011

CHADDS FORD, Pa. and BELLEVILLE, Ontario, Feb. 17, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) and Bioniche Life Sciences Inc. (TSX and ASX: BNC) today announced plans for peer-reviewed presentation of interim efficacy and safety results from the first Phase III trial of the intravesical formulation of Mycobacterial cell wall-DNA complex (MCC), known as Urocidin™ or EN3348. The results to be presented have been generated from an ongoing Phase III registration trial with Urocidin™ in the treatment of non-muscle-invasive bladder cancer (NMIBC) that is refractory to current first-line therapy (Bacillus Calmette-Guerin, known as BCG).

The first abstract and poster summaries of such results will be made available during the Annual Congress of the European Association of Urology (EAU) March 18-22 in Vienna, Austria. The accepted abstract is now available to EAU members. Further disclosure of results from this trial will be made during a podium presentation at the annual American Urological Association (AUA) meeting May 14-19 in Washington, D.C.

Phase III Results

The EAU and AUA abstracts highlight results based on an interim analysis of the Phase III trial.  The objective of the trial is to evaluate the efficacy and safety of Urocidin™ in patients with non-muscle-invasive bladder cancer (NMIBC) who are refractory to intravesical BCG therapy and at high risk of progression. A total of 129 patients were enrolled from 25 centers in the U.S. and Canada, with high grade papillary and/or carcinoma in situ (CIS) and having failed to respond to one or more courses of BCG. The overall one-year disease-free survival (DFS) rate was 25 percent. DFS is defined as lack of recurrence or progression to muscle-invasive disease, as confirmed by biopsy.  The one-year DFS rates, when sub-divided by tumor type (e
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014  Cannabis Science, ... cannabis formulation-based drug development and related consulting, is ... third international medical cannabis conference taking place at ... France , on October 22, 2014.  The ... stakeholders, such as researchers, health professionals, and patients, ...
(Date:8/22/2014)... TORONTO , Aug. 22, 2014 /PRNewswire/ - ... company that develops and commercializes proprietary technologies and ... it has entered into a Master Service Agreement ... their DNA-based pathogen detection assays. During the initial ... to deliver an automated working prototype of one ...
(Date:8/21/2014)... Conn. , Aug. 21, 2014  Aptuit ... West Lafayette, Indiana , has enhanced ... and characterization of small and large molecules, including ... of the Bruker maXisPlus Q-TOF mass spectrometer. ... Goldman , CEO, Aptuit, said, "The expanded large ...
Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2
... Aug. 19 On August 3, Macquarie University ... with its new Leksell Gamma Knife® Perfexion™ ... capable of providing dedicated intracranial radiosurgery. MUH and the ... Care, Australia,s leading provider of cancer management services, to ...
... EAU CLAIRE, Wis., Aug. 19 Leaders from healthcare, technology ... a day-long session in the Chippewa Valley technology corridor. Participants ... help overcome some of the biggest challenges facing the healthcare ... the summit which will be emceed by Dr. David Rhees, ...
Cached Medicine Technology:Treatment with Elekta's Leksell Gamma Knife Perfexion Introduced to Cancer Patients in Australia 2Treatment with Elekta's Leksell Gamma Knife Perfexion Introduced to Cancer Patients in Australia 3Leaders to Discuss Future of Healthcare and Technology on Aug. 24 2Leaders to Discuss Future of Healthcare and Technology on Aug. 24 3
(Date:8/23/2014)... MPWMD Board of Directors voted on Monday, August 18th to ... water for commercial and industrial properties. This was accomplished ... LLC in Carmel, California. , This is a historical ... in the State of California has approved this technology for ... time can now be used as a sole source of ...
(Date:8/23/2014)... TX (PRWEB) August 23, 2014 Youth ... of Texas. It’s no different in Houston, TX. Substance ... are falling victim to drug and alcohol dependency in ... are looking to beat substance abuse, but don’t know ... juvenile treatment facility can be a challenge because most ...
(Date:8/22/2014)... August 23, 2014 The IT manager ... reseller hosting for several years. He has recently announced ... best hosting suppliers in 2014. , GoDaddy is a ... rich features and great hosting solutions at affordable rates. ... price for shared hosting plans depend on the length ...
(Date:8/22/2014)... Vegas, NV (PRWEB) August 22, 2014 ... email marketing services that currently helps more than ... efforts has caught the attention of Shane Michaels, prompting ... still a crucial element for any online marketing campaign, ... replacing email in the marketing world,” reports Michaels. “AWeber ...
(Date:8/22/2014)... Sacramento, CA (PRWEB) August 22, 2014 Buying ... to an adult who is unsure about available coverage types ... now providing principal life insurance policy pricing to the public ... The use of this tool is free and is expected ... are available to the public throughout the U.S. The system ...
Breaking Medicine News(10 mins):Health News:Historical Moment in the Monterey Peninsula, Brings Drought Relief Solution to California, with the Help of EcoloBlue and AWG Technology 2Health News:New Houston Hotline Assisting Juveniles in Locating Dependable Rehabilitation Help 2Health News:AWeber: Review Exposes Affordable Provider of Opt-In Email Marketing Services 2Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2
... Source Endurance is pleased to,announce that it ... Sports and,Fitness of San Marcos Texas to collaborate ... encompass several areas of,collaboration including the sharing and ... training approaches, and deployment of one,of the first ...
... 10 with serious trauma live, often with little visible damage, ... five years of war in Iraq, there,s some relatively ... 90 percent are now surviving injuries that would have been ... of The Journal of Craniofacial Surgery , the surgical ...
... WASHINGTON, March 24 The following is a,statement ... the Supreme,Court decision today declining AARP,s request to ... eliminate health benefits for retirees when,they reach 65 ... the Equal,Employment Opportunity Commission (EEOC) finalized and published ...
... Psoriasis patients urged to discuss risk factors with ... It has long been known that,psoriasis, a chronic ... itch and bleed, can have a significant negative ... dermatologists are finding that,psoriasis, especially severe psoriasis, is ...
... Could Change The Outcome Of This ... Year,s Presidential Election, MIAMI, March 24 With ... Hillary Clinton and,Barack Obama,s stress levels are at an all time high. ... city making,numerous public appearances. This can cause lack of sleep and lack ...
... OTTAWA, March 24 Natural,Nutrition, Inc. (OTC Bulletin ... subsidiary, CSI Business Finance, Inc., has been,renamed i-Nutrition, ... third,quarter 10Q, the lending activities of CSI Business ... been made, and all proceeds from loan payments,received ...
Cached Medicine News:Health News:Source Endurance and So High Sports Announce Research Alliance for Physiology and Human Performance 2Health News:Source Endurance and So High Sports Announce Research Alliance for Physiology and Human Performance 3Health News:Innovative Care Is Helping Iraq War's Injured Survive 2Health News:Innovative Care Is Helping Iraq War's Injured Survive 3Health News:AARP 'Deeply Disappointed' by Supreme Court Decision on Retiree Health Care Benefits 2Health News:Research Shows Patients With Psoriasis at Increased Risk for Developing Other Serious Medical Conditions 2Health News:Research Shows Patients With Psoriasis at Increased Risk for Developing Other Serious Medical Conditions 3Health News:Research Shows Patients With Psoriasis at Increased Risk for Developing Other Serious Medical Conditions 4Health News:Stress On The Campaign Trail, One Issue All The Candidates Agree On 2Health News:Natural Nutrition Renames Former Business Lending Subsidiary i-Nutrition, Inc. 2
Adsons bayonet forceps....
... designed to accept rigid fixation ... an excellent reconstructive option for ... blowout defects. Each design has ... one or more rigid fixation ...
... Rim is designed to augment ... the midface, including the inferior ... positioned in the hollow under ... Rim implant aids in restoring ...
Flattened points in vertical plane, straight shafts, cross action, round handle....
Medicine Products: